Oxidation of heparin-treated low density lipoprotein by peroxidases

Atherosclerosis

Volumn 146, Issue 2, 1999, Pages 211-219

  Upritchard, Jane E ^a   Sutherland, Wayne H F ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Antioxidants; Glycosaminoglycans; Heparin; Low density lipoproteins; Peroxidases; Serum inhibitors

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BUTYLCRESOL; GLYCOSAMINOGLYCAN; HEPARIN; LOW DENSITY LIPOPROTEIN; MYELOPEROXIDASE; PEROXIDASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UREA;

ARTICLE; ATHEROGENESIS; HUMAN; LIPID PEROXIDATION; OXIDATION; PRIORITY JOURNAL;

ANTIOXIDANTS; ARTERIES; ARTERIOSCLEROSIS; BINDING SITES; BUTYLATED HYDROXYTOLUENE; HEPARIN; HORSERADISH PEROXIDASE; HUMANS; HYDROGEN PEROXIDE; LIPOPROTEINS, LDL; OXIDATION-REDUCTION; PEROXIDASE; PEROXIDASES; PROTEOGLYCANS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TUNICA INTIMA; TYROSINE;

EID: 0032868955     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00127-6     Document Type: Article

References (39)

1. Williams K.J., Tabas I. The response-to-retention hypothesis of early atherosclerosis. Arterioscler Thromb Vasc Biol. 15:1995;551.
2. Berliner J.A., Heinecke J.W. The role of oxidised lipoproteins in atherogenesis. Free Radic Biol Med. 20:1996;707.
3. Hurt-Camejo E., Olsson U., Wiklund O., Bondjers G., Camejo G. Cellular consequences of the association of apo B lipoproteins with proteoglycans. Potential contribution to atherogenesis. Arterioscler Thromb Vasc Biol. 17:1997;1011.
4. Vijayagopal P., Srinivasan S.R., Radhakrishnamurthy B., Berenson G.S. Interaction of serum lipoproteins and a proteoglycan from bovine aorta. J Biol Chem. 256:1981;8224.
5. Camejo G., Hurt-Camejo E., Rosengren B., Wiklund O., López F., Bondjers G. Modification of copper-catalysed oxidation of low density lipoprotein by proteoglycans and glycosaminoglycans. J Lipid Res. 32:1991;1983.
6. Camejo G., Hurt-Camejo E., Wiklund O., Bondjers G. Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis. Atherosclerosis. 139:1998;205.
7. Camejo G., Hurt E., Romano M. Properties of lipoprotein complexes isolated by affinity chromatography from human aorta. Biomed Biochim Acta. 44:1985;389.
8. Vijayagopal P., Srinivasan S.R., Radhakrishnamurthy B., Berenson G.S. Lipoprotein-proteoglycan complexes from atherosclerotic lesions promote cholesteryl ester accumulation in human monocyte/macrophages. Arterioscler Thromb. 12:1992;237.
9. Mateu L., Avila E.M., Camejo G., León V., Liscano N. The structural stability of low density lipoprotein. A kinetic X-ray scattering study of its interaction with arterial proteoglycans. Biochim Biophys Acta. 795:1984;525.
10. Bihari-Varga M., Camejo G., Christiane-Horn M., Szabo D., Löpez F., Gruber E. Structure of low density lipoprotein in complexes formed with arterial matrix components. Int J Biol Macromol. 5:1983;59.
11. Camejo G., Hurt E., Wiklund O., Rosengren B., López F., Bondjers G. Modification of low-density lipoprotein induced by arterial proteoglycans and chondroitin-6-sulphate. Biochim Biophys Acta. 1096:1991;253.
12. Hurt E., Bondjers G., Camejo G. Interaction of LDL with human arterial proteoglycans stimulates its uptake by human monocyte-derived macrophages. J Lipid Res. 31:1990;443.
13. Ylä-Herttuala S., Palinski W., Rosenfeld M.E. et al. Evidence for presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest. 84:1989;1086.
14. Hermann M., Gmeiner B. Altered susceptibility to in vitro oxidation of LDL in LDL complexes and LDL aggregates. Arterioscler Thromb. 12:1992;1503.
15. Dabbagh A.J., Frei B. Human suction blister interstitial fluid prevents metal-ion dependent oxidation of low density lipoprotein by macrophages and in cell-free systems. J Clin Invest. 96:1995;1958.
16. Ehrenwald E., Chisolm G.M., Fox P.L. Intact human ceruloplasmin oxidatively modifies low density lipoprotein. J Clin Invest. 93:1994;1493.
17. Sutherland W.H.F. Oxidation of heparin-isolated LDL by hemin. The effect of serum components. Arterioscler Thromb. 14:1994;1966.
18. Hazell S.L., Heinecke J.W. 3-Chlorotyrosine, a specific marker of MPO-catalysed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest. 99:1997;2075.
19. Harrison J.E., Schultz J. Studies on the chlorinating activity of myeloperoxidase. J Biol Chem. 251:1976;1371.
20. Daugherty A., Dunn J.L., Rateri D.L., Heinecke J.W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest. 94:1994;437.
21. Hazell L.J., Stocker R. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form. Biochem J. 290:1993;165.
22. Santanam N., Parthasarathy S. Paradoxical actions of antioxidants in the oxidation of low density lipoprotein by peroxidases. J Clin Invest. 95:1995;2594.
23. Kalyanaraman B., Darley-Usmar V., Struck A., Hogg N., Parthasarathy S. Role of apolipoprotein B-derived radical and alpha-tocopherol radical in peroxidase-dependent oxidation of low density lipoprotein. J Lipid Res. 36:1995;1037.
24. Wieland E., Parthasarathy S., Steinberg D. Peroxidase-dependent metal-independent oxidation of low density lipoprotein in vitro: a model for in vivo oxidation? Proc Natl Acad Sci USA. 90:1993;5929.
25. Lindgren F.T., Jensen L.C. The isolation of serum lipoproteins. Nelson G.J. Blood Lipids and Lipoproteins: Quantitation, Composition, and Metabolism. 1979;181-274 Kreiger, New York.
26. Gieseg S.P., Esterbauer H. Low density lipoprotein is saturable by pro-oxidant copper. FEBS Lett. 343:1994;188.
27. 3 quantitation method based on precipitation with polyethyleneglycol. Clin Chim Acta. 148:1985;139.
28. Khoo J.C., Miller E., McLoughlin P., Steinberg D. Enhanced macrophage uptake of low density lipoprotein after self-aggregation. Arteriosclerosis. 8:1988;348.
29. 2+ precipitation procedure for quantification of high density lipoprotein cholesterol. Clin Chem. 28:1982;1379.
30. Beuge J.A., Aust S.D. Microsomal lipid peroxidation. Methods Enzymol. 52:1978;302.
31. Watson A.D., Berliner J.A., Hama S.Y. et al. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidised low density lipoprotein. J Clin Invest. 96:1995;2882.
32. Wasowicz W., Nève J., Peretz A. Optimized steps in fluorimetric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem. 39:1993;2522.
33. Demacher P.N.M., Hijmans A.G.M., Vos-Jansen H.E., van't Laar A., Jansen A.P. A study of the use of polyethylene glycol in estimating cholesterol in high-density lipoprotein. Clin Chem. 26:1980;1775.
34. Hurt E., Camejo G. Effect of arterial proteoglycans on the interaction of LDL with human-derived macrophages. Atherosclerosis. 67:1987;115.
35. Retsky K.L., Freeman M.W., Frei B. Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. Anti- rather than prooxidant activity of vitamin C in the presence of transition metal ions. J Biol Chem. 268:1993;1304.
36. Bowry V.W., Stocker R. Tocopherol-mediated peroxidation. The pro-oxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. J Am Chem Soc. 115:1993;6029.
37. Savenkova M.I., Mueller D.M., Heinecke J.W. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein. J Biol Chem. 269:1994;20394.
38. Zeng J., Fenna R.E. X-ray crystal structure of canine myeloperoxidase at 3 Å resolution. J Mol Biol. 226:1992;185.
39. Vessby B., Gustafson S., Chapman M.J., Hellsing K., Lithell H. Lipoprotein composition of human suction-blister interstitial fluid. J Lipid Res. 28:1987;629.